About Castle Creek Pharma
Castle Creek Pharma is a company based in Basking Ridge (United States) founded in 2015.. Castle Creek Pharma has raised $663.15 million across 3 funding rounds from investors including Fidelity Investments and Valor Equity Partners. The company has 72 employees as of December 31, 2021. Castle Creek Pharma has completed 1 acquisition, including Fibrocell Science. Castle Creek Pharma operates in a competitive market with competitors including Amryt Pharma, Castle Creek Biosciences, QID Pharma, Eicos Sciences and LifeMax, among others.
- Headquarter Basking Ridge, United States
- Employees 72 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$663.15 M (USD)
in 3 rounds
-
Latest Funding Round
$54.6 M (USD), Series C
Dec 09, 2019
-
Investors
Fidelity Investments
& 1 more
-
Employee Count
72
as on Dec 31, 2021
- Investments & Acquisitions
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Castle Creek Pharma
Castle Creek Pharma has successfully raised a total of $663.15M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $54.6 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $54.6M
-
First Round
First Round
(17 Oct 2016)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series C - Castle Creek Pharma | Valuation |
investors |
|
| Oct, 2018 | Amount | Series C - Castle Creek Pharma | Valuation | Fidelity Investments , Valor Equity Partners |
|
| Oct, 2016 | Amount | Series B - Castle Creek Pharma | Valuation | Fidelity Investments |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Castle Creek Pharma
Castle Creek Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Fidelity Investments and Valor Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm
|
Founded Year | Domain | Location | |
|
Provider of brokerage accounts, retirement planning, wealth management, and trading platforms
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Castle Creek Pharma
Castle Creek Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fibrocell Science. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Developer of autologous cell and gene therapies for diseases of the skin, connective tissue and joints
|
1995 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Castle Creek Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Castle Creek Pharma Comparisons
Competitors of Castle Creek Pharma
Castle Creek Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Amryt Pharma, Castle Creek Biosciences, QID Pharma, Eicos Sciences and LifeMax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for rare dermatological and orphan diseases are developed.
|
|
| domain | founded_year | HQ Location |
Gene therapy platform for rare disease treatments is developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for rare genetic dermatology disorders are developed.
|
|
| domain | founded_year | HQ Location |
Develops Prostacyclin-based therapies for underserved medical conditions globally.
|
|
| domain | founded_year | HQ Location |
Develops innovative therapeutic solutions for Netherton syndrome treatment.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Castle Creek Pharma
Frequently Asked Questions about Castle Creek Pharma
When was Castle Creek Pharma founded?
Castle Creek Pharma was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Where is Castle Creek Pharma located?
Castle Creek Pharma is headquartered in Basking Ridge, United States. It is registered at Basking Ridge, New Jersey, United States.
Who is the current CEO of Castle Creek Pharma?
Matthew Gantz is the current CEO of Castle Creek Pharma.
Is Castle Creek Pharma a funded company?
Castle Creek Pharma is a funded company, having raised a total of $663.15M across 3 funding rounds to date. The company's 1st funding round was a Series B of $48M, raised on Oct 17, 2016.
How many employees does Castle Creek Pharma have?
As of Dec 31, 2021, the latest employee count at Castle Creek Pharma is 72.
What does Castle Creek Pharma do?
Castle Creek Pharma, part of Paragon Biosciences, is developing drugs for skin diseases, ENT disorders, and rare diseases such as urea cycle disorders (UCDs). Its drug pipeline includes CCP-020 (diacerein 1 ointment) for the treatment of Epidermolysis Bullosa Simplex (Phase 3); CCP-040 which is in development for the treatment of oral and head and neck cancers (preclinical), as an adjuvant therapy to prevent recurrence; CCP-010, a molecular chaperone that is being developed as the first treatment option for patients with GM2 Gangliosidosis (Tay-Sachs and Sandhoff disease), a lysosomal storage disorder (Phase 23); CCP-110, in development for the treatment of hyperammonemia in UCDs (Phase 12) that acts by trapping ammonia ions in the gut and rapidly excreting them from the body.
Who are the top competitors of Castle Creek Pharma?
Castle Creek Pharma's top competitors include Castle Creek Biosciences, Amryt Pharma and QID Pharma.
How many acquisitions has Castle Creek Pharma made?
Castle Creek Pharma has made 1 acquisition, including Fibrocell Science.
Who are Castle Creek Pharma's investors?
Castle Creek Pharma has 2 investors. Key investors include Fidelity Investments, and Valor Equity Partners.